Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen, Bionomics to Co-Develop Molecular Diagnostic for Epilepsy

NEW YORK, Oct. 1 - Nanogen and Bionomics today said they will work together to develop what they believe will be the world's first molecular-diagnostic test for epilepsy.


Under the terms of the collaboration, the partners will use Nanogen's NanoChip technology together with Bionomics' ionX discovery platform.


Though no financial details were disclosed, the companies agreed that Nanogen would hold exclusive license to any diagnostic-related IP that comes out of the collaboration. In return, Bionomics will be handed funding for research, as well as undisclosed payments for development and commercialization milestones.


Click here for more information.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.